Cutting edge: New chimeric NOD2/TLR2 adjuvant drastically increases vaccine immunogenicity

Journal of Immunology

Volumn 193, Issue 12, 2014, Pages 5781-5785

  Pavot, Vincent ^a   Rochereau, Nicolas ^a   Rességuier, Julien ^a   Gutjahr, Alice ^a,b   Genin, Christian ^a   Tiraby, Gerard ^b   Perouzel, Eric ^b   Lioux, Thierry ^b   Vernejoul, Fabienne ^b   Verrier, Bernard ^a   Paul, Stéphane ^a  

^a UNIVERSITÉ DE LYON   (France)

^b Zone industrielle de Montaudran   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOKINE; GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MURABUTIDE; NANOPARTICLE; POLYLACTIC ACID; TOLL LIKE RECEPTOR 2; BIOLOGICAL MARKER; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; LIGAND; LIPOPEPTIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE; N-ACETYLMURAMYL-ALANYLGLUTAMINE-N-BUTYL ESTER; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; EMBRYO; FEMALE; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VITRO STUDY; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; BLOOD; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; PHENOTYPE;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; FEMALE; HIV CORE PROTEIN P24; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIGANDS; LIPOPEPTIDES; MICE; NOD2 SIGNALING ADAPTOR PROTEIN; PHENOTYPE; TOLL-LIKE RECEPTOR 2; VACCINES;

EID: 84916900222     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402184     Document Type: Article

References (34)

1. Delany, I., R. Rappuoli, and E. De Gregorio. 2014. Vaccines for the 21st century. EMBO Mol. Med. 6: 708-720.
2. Duthie, M. S., H. P. Windish, C. B. Fox, and S. G. Reed. 2011. Use of defined TLR ligands as adjuvants within human vaccines. Immunol. Rev. 239: 178-196.
3. Geddes, K., J. G. Magalhães, and S. E. Girardin. 2009. Unleashing the therapeutic potential of NOD-like receptors. Nat. Rev. Drug Discov. 8: 465-479.
4. Timmermans, K., T. S. Plantinga, M. Kox, M. Vaneker, G. J. Scheffer, G. J. Adema, L. A. Joosten, and M. G. Netea. 2013. Blueprints of signaling interactions between pattern recognition receptors: implications for the design of vaccine adjuvants. Clin. Vaccine Immunol. 20: 427-432.
5. Fritz, J. H., S. E. Girardin, C. Fitting, C. Werts, D. Mengin-Lecreulx, M. Caroff, J. M. Cavaillon, D. J. Philpott, and M. Adib-Conquy. 2005. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Eur. J. Immunol. 35: 2459-2470.
6. Uehara, A., S. Yang, Y. Fujimoto, K. Fukase, S. Kusumoto, K. Shibata, S. Sugawara, and H. Takada. 2005. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell. Microbiol. 7: 53-61.
7. Tada, H., S. Aiba, K. Shibata, T. Ohteki, and H. Takada. 2005. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect. Immun. 73: 7967-7976.
8. Fritz, J. H., L. Le Bourhis, G. Sellge, J. G. Magalhaes, H. Fsihi, T. A. Kufer, C. Collins, J. Viala, R. L. Ferrero, S. E. Girardin, and D. J. Philpott. 2007. Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 26: 445-459.
9. Magalhaes, J. G., J. H. Fritz, L. Le Bourhis, G. Sellge, L. H. Travassos, T. Selvanantham, S. E. Girardin, J. L. Gommerman, and D. J. Philpott. 2008. Nod2-dependent Th2 polarization of antigen-specific immunity. J. Immunol. 181: 7925-7935.
10. Kobayashi, K. S., M. Chamaillard, Y. Ogura, O. Henegariu, N. Inohara, G. Nuñez, and R. A. Flavell. 2005. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307: 731-734.
11. Kornbluth, R. S., and G. W. Stone. 2006. Immunostimulatory combinations: designing the next generation of vaccine adjuvants. J. Leukoc. Biol. 80: 1084-1102.
12. Borrello, S., C. Nicolò, G. Delogu, F. Pandolfi, and F. Ria. 2011. TLR2: a cross-roads between infections and autoimmunity? Int. J. Immunopathol. Pharmacol. 24: 549-556.
13. Liang, Y., H. Hasturk, J. Elliot, A. Noronha, X. Liu, L. M. Wetzler, P. Massari, A. Kantarci, H. S. Winter, F. A. Farraye, and L. M. Ganley-Leal. 2011. Toll-like receptor 2 induces mucosal homing receptor expression and IgA production by human B cells. Clin. Immunol. 138: 33-40.
14. Rubino, S. J., T. Selvanantham, S. E. Girardin, and D. J. Philpott. 2012. Nod-like receptors in the control of intestinal inflammation. Curr. Opin. Immunol. 24: 398-404.
15. Cooney, R., J. Baker, O. Brain, B. Danis, T. Pichulik, P. Allan, D. J. Ferguson, B. J. Campbell, D. Jewell, and A. Simmons. 2010. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat. Med. 16: 90-97.
16. Pavot, V., N. Rochereau, C. Primard, C. Genin, E. Perouzel, T. Lioux, S. Paul, and B. Verrier. 2013. Encapsulation of Nod1 and Nod2 receptor ligands into poly(lactic acid) nanoparticles potentiates their immune properties. J. Control. Release 167: 60-67.
17. Bohnenkamp, H. R., and T. Noll. 2003. Development of a standardized protocol for reproducible generation of matured monocyte-derived dendritic cells suitable for clinical application. Cytotechnology 42: 121-131.
18. Morris, S., M. S. Swanson, A. Lieberman, M. Reed, Z. Yue, D. M. Lindell, and N. W. Lukacs. 2011. Autophagy-mediated dendritic cell activation is essential for innate cytokine production and APC function with respiratory syncytial virus responses. J. Immunol. 187: 3953-3961.
19. Triantafilou, M., M. Manukyan, A. Mackie, S. Morath, T. Hartung, H. Heine, and K. Triantafilou. 2004. Lipoteichoic acid and toll-like receptor 2 internalization and targeting to the Golgi are lipid raft-dependent. J. Biol. Chem. 279: 40882-40889.
20. Nilsen, N. J., S. Deininger, U. Nonstad, F. Skjeldal, H. Husebye, D. Rodionov, S. von Aulock, T. Hartung, E. Lien, O. Bakke, and T. Espevik. 2008. Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36. J. Leukoc. Biol. 84: 280-291.
21. Lee, J., I. Tattoli, K. A. Wojtal, S. R. Vavricka, D. J. Philpott, and S. E. Girardin. 2009. pH-dependent internalization of muramyl peptides from early endosomes enables Nod1 and Nod2 signaling. J. Biol. Chem. 284: 23818-23829.
22. Nakamura, N., J. R. Lill, Q. Phung, Z. Jiang, C. Bakalarski, A. de Mazière, J. Klumperman, M. Schlatter, L. Delamarre, and I. Mellman. 2014. Endosomes are specialized platforms for bacterial sensing and NOD2 signalling. Nature 509: 240-244.
23. Landström, M. 2010. The TAK1-TRAF6 signalling pathway. Int. J. Biochem. Cell Biol. 42: 585-589.
24. Hasegawa, M., Y. Fujimoto, P. C. Lucas, H. Nakano, K. Fukase, G. Núñez, and N. Inohara. 2008. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. EMBO J. 27: 373-383.
25. Zhao, L., A. Seth, N. Wibowo, C. X. Zhao, N. Mitter, C. Yu, and A. P. Middelberg. 2014. Nanoparticle vaccines. Vaccine 32: 327-337.
26. Kuo, T. T., K. Baker, M. Yoshida, S. W. Qiao, V. G. Aveson, W. I. Lencer, and R. S. Blumberg. 2010. Neonatal Fc receptor: from immunity to therapeutics. J. Clin. Immunol. 30: 777-789.
27. Johansen, F. E., and C. S. Kaetzel. 2011. Regulation of the polymeric immunoglobulin receptor and IgA transport: new advances in environmental factors that stimulate pIgR expression and its role in mucosal immunity. Mucosal Immunol. 4: 598-602.
28. O'Neill, L. A. 2011. Synergism between NOD-like receptors and Toll-like receptors in human B lymphocytes. J. Leukoc. Biol. 89: 173-175.
29. Takada, H., and A. Uehara. 2006. Enhancement of TLR-mediated innate immune responses by peptidoglycans through NOD signaling. Curr. Pharm. Des. 12: 4163-4172.
30. Takatsu, K., T. Kouro, and Y. Nagai. 2009. Interleukin 5 in the link between the innate and acquired immune response. Adv. Immunol. 101: 191-236.
31. Goswami, R., and M. H. Kaplan. 2011. A brief history of IL-9. J. Immunol. 186: 3283-3288.
32. Elyaman, W., E. M. Bradshaw, C. Uyttenhove, V. Dardalhon, A. Awasthi, J. Imitola, E. Bettelli, M. Oukka, J. van Snick, J. C. Renauld, et al. 2009. IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc. Natl. Acad. Sci. USA 106: 12885-12890.
33. Dubin, P. J., and J. K. Kolls. 2008. Th17 cytokines and mucosal immunity. Immunol. Rev. 226: 160-171.
34. Elgueta, R., M. J. Benson, V. C. de Vries, A. Wasiuk, Y. Guo, and R. J. Noelle. 2009. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol. Rev. 229: 152-172.